Lymphocyte-Activation Gene 3 (LAG3) Peptide
-
- Target See all LAG3 products
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- GFHLWRRQWR PRRFSALEQG IHPPQAQSKI EELEQEPEPE PEPEPEPEPE
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LAG3 antibody,
Alternative Names: LAG3 control peptide, LAG3 antibody Blocking Peptide, Anti-LAG3 Blocking Peptide, lymphocyte-activation gene 3 Blocking Peptide, CD223 Blocking Peptide, LAG3, LAG-3, LAG 3, LAG-3 Blocking Peptide, LAG 3 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
- Background
- Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4.
- Molecular Weight
- 55 kDa
-